Initial real-life experience with ocrelizumab in patients with relapsing-remitting and primary progressive multiple sclerosis in Salzburg, Austria
Feige, J; Moser, T; Nagy, Z; Otto, F; Wipfler, P; Trinka, E; Sellner, J;
EUR J NEUROL. 2019; 26: 489-489.
Abstracts (Zeitschrift)